Search Results - "Matulich PJ"

Circulating T cells fuel anti-PD-1 and lenvatinib efficacy.

Authors: Matulich PJ Burger ML

Source: Cancer cell [Cancer Cell] 2025 Feb 10; Vol. 43 (2), pp. 173-175. Date of Electronic Publication: 2025 Jan 30.

Publication Type: Journal Article

Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Comparative efficacy of tislelizumab plus lenvatinib and tislelizumab alone against advanced hepatocellular carcinoma after lenvatinib failure: a real-world study.

Authors: Yang, Jiajin Xu, Qiuping Luo, Sihao et al.

Source: BMC Cancer. 4/16/2025, Vol. 25 Issue 1, p1-10. 10p.